Monitoring the activity of direct oral anticoagulants in a patient with severe nephrotic syndrome and pulmonary embolism. Lessons for the clinical nephrologist.

Laslandes M, Connault J, Nicolet L, Ternisien C, Gregoire M, Ville S, Dantal J, Masset C

Open source

DOI
10.1007/s40620-022-01406-w
Published
2023 Jan
Container
Journal of nephrology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40620-022-01406-w,
  title = {Monitoring the activity of direct oral anticoagulants in a patient with severe nephrotic syndrome and pulmonary embolism. Lessons for the clinical nephrologist.},
  author = {Laslandes M and Connault J and Nicolet L and Ternisien C and Gregoire M and Ville S and Dantal J and Masset C},
  year = {2023},
  journal = {Journal of nephrology},
  doi = {10.1007/s40620-022-01406-w},
  url = {https://doi.org/10.1007/s40620-022-01406-w}
}

RIS

TY  - JOUR
TI  - Monitoring the activity of direct oral anticoagulants in a patient with severe nephrotic syndrome and pulmonary embolism. Lessons for the clinical nephrologist.
AU  - Laslandes M
AU  - Connault J
AU  - Nicolet L
AU  - Ternisien C
AU  - Gregoire M
AU  - Ville S
AU  - Dantal J
AU  - Masset C
PY  - 2023
JO  - Journal of nephrology
DO  - 10.1007/s40620-022-01406-w
UR  - https://doi.org/10.1007/s40620-022-01406-w
ER  - 

APA

M, L., J, C., L, N., C, T., M, G., S, V., J, D., & C, M. (2023). Monitoring the activity of direct oral anticoagulants in a patient with severe nephrotic syndrome and pulmonary embolism. Lessons for the clinical nephrologist.. Journal of nephrology. https://doi.org/10.1007/s40620-022-01406-w

Source records